About
Vergent Bioscience is a clinical-stage biotechnology company developing tumor-targeted fluorescent imaging agents to enable real-time visualization of tumors during minimally invasive and robotic-assisted cancer surgeries, primarily focusing on lung cancer.
Explore Vergent Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.